Patent · US Active

Pyrrolopyrimidine compounds and their uses

US8324225B2 · kind B2 · utility

36Cited by
1References
9Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMay 24, 2007
Grant dateDec 4, 2012
Priority date
Expiry dateMay 29, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D487/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present application describes organic compounds that are useful for the treatment, prevention and/or amelioration of diseases, particularly pyrrolopyrimidine compounds and derivatives are described which inhibit protein kinases. The organic compounds are useful in treating proliferative disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.